The Technical AnalystExchange: SAU Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Saudi Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.07% SAR37.75
America/New_York / 25 apr 2024 @ 08:18
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4 530.00 mill |
| EPS: | -0.160 |
| P/E: | -235.94 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 120.00 mill |
| Avg Daily Volume: | 1.085 mill |
| RATING 2024-04-25 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -235.94 | sector: PE 39.17 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -3.09x |
| Company: PE -235.94 | industry: PE 76.32 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SAR-24.80 (-165.71%) SAR-62.55 |
| Date: 2024-04-27 |
| Expected Trading Range (DAY) |
|---|
|
SAR 36.19 - 39.31 ( +/- 4.14%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SAR37.75 (1.07% ) |
| Volume | 0.439 mill |
| Avg. Vol. | 1.085 mill |
| % of Avg. Vol | 40.46 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 2070.SR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
2070.SR
Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; and wholesale and retail of medicines and related products. In addition, it develops, manufactures, and sells pharmaceutical products and medical appliances; operates and maintains healthcare facilities. Further, the company engages in the research and development of medical science. The company was founded in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.